{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"GlycoMimetics, Inc."},"Symbol":{"label":"Symbol","value":"GLYC"},"Address":{"label":"Address","value":"9708 MEDICAL CENTER DRIVE, ROCKVILLE, Maryland, 20850, United States"},"Phone":{"label":"Phone","value":"+1 240 243-1201"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"GlycoMimetics Inc is a clinical stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it plays in inflammation, cancer, and infection."},"CompanyUrl":{"label":"Company Url","value":"https://www.glycomimetics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Gaetano Bonifacio","title":"Vice President-Global Medical Affairs"},{"name":"Harout Semerjian","title":"President, Chief Executive Officer & Director"},{"name":"Martina Hemmer","title":"Vice President-Clinical Operations"},{"name":"Shantha Tyavanagimatt","title":"Senior Vice President-Technical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}